期刊文献+

醒脑静注射液治疗肝癌高血氨症19例临床观察

醒脑静注射液治疗肝癌高血氨症19例临床观察
下载PDF
导出
摘要 目的:探讨醒脑静注射液对肝癌高血氨症的疗效。方法:将38例肝癌高血氨症患者随机分为治疗组和对照组,所有患者均给予常规治疗,治疗组加用醒脑静注射液20ml/d,静脉滴注。观察期间两组病人均不予特别饮食干预。治疗2周后检测血氨水平及精神、神经系统变化。结果:2周后,治疗组治疗后血氨显著降低,具有显著性差异(P<0.01)。精神、神经系统亦能显著改善,两组病人比较有显著性差异(P<0.01)。结论:醒脑静注射液对降低肝癌高血氨,预防肝性脑病有效、方便、安全。 Objective:Explore XNJI of hyperammonemia on the efficacy of liver cancer.Method:The 38 cases of liver cancer hyperammonemia were randomly divided into treatment and control groups,all patients were given conventional treatment,treatment group XNJI,20 ml / d,intravenous infusion.Two groups of patients were not observed during the special dietary intervention.2 weeks after the detection of blood ammonia levels and mental and nervous system changes.Result:After 2 weeks after treatment,significantly reduced blood ammonia,with a significant difference(P 0.01).Mental,nervous system also improved significantly,two groups of patients had significant differences(P 0.01).Conclusion:XNJI high blood ammonia to reduce liver cancer,prevention of hepatic encephalopathy effective,convenient and safe.
作者 吴锦燕 黄希
出处 《内蒙古中医药》 2011年第24期26-27,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
  • 相关文献

参考文献4

二级参考文献15

  • 1贾林.我国轻微型肝性脑病的研究现状[J].世界华人消化杂志,2004,12(6):1261-1263. 被引量:18
  • 2贾林,张美华,杜洪,苏常青,李泽.双歧三联活菌对鼠轻微型肝性脑病模型的实验治疗及机制[J].中华消化杂志,2004,24(9):552-553. 被引量:11
  • 3孟庆林,胡长欣,候廷奎.盐酸纳洛酮拮抗乙醇中毒作用机理的探讨[J].中国急救医学,1996,16(3):2-4. 被引量:361
  • 4国家中医药管理局.中风病中医诊断评定标准.中国医药学报,1986,1(2):56-56.
  • 5贾林.第11届世界胃肠大会有关肝性脑病的共识意见.见贾林.李兆申主编.肝性脑病,第1版.北京:人民军医出版社,2007;4-6.
  • 6Ferenci P, I.ockwood A, Mullen K, et al. Hepatic eneephalopa thy definition, nomenclature, diagnosis, and quantification: fina report of the working party al the 11^th World Congresses of Gas troenterology, Vienna, 1998, Hepatology, 2002, 35:710-721.
  • 7Laccetti M, Manes G, Uomo G, et al. Flumazenilin the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study. Dig Liver Dis, 21100. 32: 335-338.
  • 8Als-Nielsen B, Gluud LL, Gluud C, et al. Non absorbable disaccharides for hepalic encephalopathy: systemic review of randomized trims. BMJ, 2004, 328(7447): 1046.
  • 9Mullen KD, Ferenci P, Bass NM, et al. An algortithm for man agement of hepatic encephalopathy. Strain Liver Dis, 2007:32-48.
  • 10Arguedas MR, DeLawrenceTG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in paticrus with cirrhosis. Dis DisSci, 2003, 45: 1622-1626.

共引文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部